BSE · DECIPHER
DECIPHER LABS LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,797
of 5,088 stocks
▼ 141W
Peak #4,783 · 21 Sep 2026
DECIPHER LABS LIMITED is a microcap company in the Healthcare space and trades at an undemanding earnings multiple, is seeing revenue contract sharply, and has a subdued return on equity.
Market Cap
6.06 Cr
P/E Ratio
1.97
P/B Ratio
0.74
ROE
-37.43%
ROCE
-44.72%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 2.41 Cr | 3.60 Cr | 3.21 Cr | 4.31 Cr |
| Net Profit | -2.19 Cr | -35.79 L | -53.88 L | 2.01 L |
| EPS | 2.16 | 0.35 | 0.53 | 0.02 |
| Operating Profit | -2.19 Cr | 25.16 L | -53.31 L | 1.89 L |
Shareholding pattern
Promoter
16.43%
Public
83.57%
PUBLIC BREAKDOWN
FII
0.00%
Individuals
78.72%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 19 Sep 2011 | Other | Consolidation of Shares |
| 19 Sep 2011 | Other | Reduction of Capital |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.